• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Cardiac Implants Market

    ID: MRFR/MED/5263-CR
    163 Pages
    Rahul Gotadki
    April 2019

    Cardiac Implants Market Research Report Information by Device (Coronary Stents, Prosthetic Heart Valve Devices, & Others), Indication (Arrhythmias, Heart Failure, & Others), End User (Hospitals, Cardiac Care Centers, & Others), and Region - Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Cardiac Implants Market Infographic
    Purchase Options

    Cardiac Implants Market Summary

    The Global Cardiac Implants Market is projected to grow significantly from 44.9 USD Billion in 2024 to 125.7 USD Billion by 2035.

    Key Market Trends & Highlights

    Cardiac Implants Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 9.82% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 125.7 USD Billion, reflecting robust growth.
    • In 2024, the market is valued at 44.9 USD Billion, indicating a strong foundation for future expansion.
    • Growing adoption of advanced cardiac implant technologies due to increasing prevalence of cardiovascular diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 44.9 (USD Billion)
    2035 Market Size 125.7 (USD Billion)
    CAGR (2025-2035) 9.82%

    Major Players

    Abbott, Amg International, Edwards Life Sciences Corporation, Braun Melsungen AG, Biotronik, Boston Scientific Corporation, LivaNova PLC, Medtronic PLC, Syncardia Systems, Inc, Terumo Corporation

    Cardiac Implants Market Trends

    The growth of the cardiac implants industry is driven by factors such as growing geriatric population coupled with the increasing prevalence of cardiac diseases. Generally, the older population is more susceptible to diseases as with aging, the heart and blood vessels become stiff which can lead to conditions such as heart failure, coronary artery disease, and atrial fibrillation, among others.  According to the data published by the Centers for Disease Control and Prevention (CDC) in 2017, about 2.7 to 6.1 million people in the US had atrial fibrillation, a common form of heart arrhythmia.

    However, the high cost of cardiac implants are a risk of injections is likely to affect the growth of the market.

    Cardiac Implants Market Revenue, by End User, 2022 (USD Billion)

     

    Driver:

    Rising Prevalence of Cardiac Disease and Geriatric Population

    The rise in older adults and the rising prevalence of chronic diseases are the major drivers of the cardiac implant devices. Geriatric people are highly susceptible to chronic diseases like cardiovascular diseases, endovascular diseases, orthopedic disorders, and dental disorders, which are having the major need for medical implants. Generally, for aged people, dental disorder was a common problem. Hence with a rise in aged people, demand for tooth loss may increase. At the risk of a patient’s cardiac disorder, most healthcare organizations and hospitals prefer cardiovascular implants to provide artificial control on the patient’s heartbeat.

    Restraint:

    High Cost of Treatment and stringent approval process

    Some cardiac patients may affect infections with implantable pacemakers, which makes them avoid these products. Thus reduces the demand for cardiac implants. The high cost of treatment is also a big burden for the normal ones. Hence the demand for cardiovascular implants growth decreases.

    Opportunities:

    Increase in Awareness and technological advancements

    By increasing the awareness of different types of medical implants among healthcare professionals can boost the growth of the cardiac implants industry. By introducing the new advanced technologies in medical implants, the availability of better medical facilities, a large number of cases with damaged organs caused due to different types of accidents are the opportunities to increase the cardiac implants market share.

    Technology Analysis

    The new advanced technologies in medical implants are expected to increase the growth of the Cardiac Implants Industry.

    Study Objectives -

    To provide detailed information about the Cardiac Implants structure along with various forecast segments and sub-segments.

    To provide the factors that affect the cardiac implants market share growth.

    To analyze the cardiac implants market-based porter’s five force analysis, etc.

    To provide the country-level analysis of the current cardiac implants market size and future prospective.

    To provide country-level analysis of the cardiac monitoring device implants growth by region, device, indication, and end-user.

    To provide a strategic profile of the key players in the market, analyze their core competencies, and draw a landscape of the cardiac implants market growth.

    To track and analyze new product developments, strategic alliances, and research in the cardiac implants market.

    The Global Cardiac Implants Market is poised for growth as advancements in technology and an increasing prevalence of cardiovascular diseases drive demand for innovative therapeutic solutions.

    U.S. Food and Drug Administration (FDA)

    Cardiac Implants Market Drivers

    Market Growth Projections

    The Global Cardiac Implants Market Industry is projected to experience substantial growth in the coming years. With a compound annual growth rate (CAGR) of 9.82% anticipated from 2025 to 2035, the market is expected to expand significantly. By 2024, the market is estimated to reach 44.9 USD Billion, and by 2035, it could potentially reach 125.7 USD Billion. This growth trajectory reflects the increasing demand for cardiac implants driven by various factors, including technological advancements, an aging population, and rising healthcare expenditures. The market's expansion indicates a robust future for cardiac health solutions.

    Regulatory Support and Reimbursement Policies

    Supportive regulatory frameworks and favorable reimbursement policies are pivotal in shaping the Global Cardiac Implants Market Industry. Governments and health authorities are increasingly recognizing the importance of cardiac implants in managing heart diseases, leading to streamlined approval processes for new devices. Additionally, comprehensive reimbursement policies facilitate access to these technologies, encouraging healthcare providers to adopt them. This supportive environment fosters innovation and investment in the development of advanced cardiac implants. Consequently, the market is poised for growth, as these factors collectively enhance the accessibility and affordability of cardiac care.

    Increasing Prevalence of Cardiovascular Diseases

    The rising incidence of cardiovascular diseases globally is a primary driver of the Global Cardiac Implants Market Industry. As lifestyle-related factors such as obesity, sedentary behavior, and unhealthy diets continue to escalate, the demand for cardiac implants is likely to increase. For instance, cardiovascular diseases account for approximately 31% of all global deaths, highlighting the urgent need for effective treatment options. This growing health crisis is expected to propel the market, which is projected to reach 44.9 USD Billion in 2024, indicating a robust demand for innovative cardiac solutions.

    Technological Advancements in Implantable Devices

    Technological innovations in implantable cardiac devices are transforming the Global Cardiac Implants Market Industry. Advancements such as bioresorbable stents, leadless pacemakers, and remote monitoring capabilities enhance the efficacy and safety of cardiac implants. These innovations not only improve patient outcomes but also reduce the risk of complications, thereby increasing adoption rates among healthcare providers. The integration of artificial intelligence and machine learning into these devices further personalizes treatment, potentially leading to better management of cardiovascular conditions. As a result, the market is anticipated to experience significant growth, driven by these cutting-edge technologies.

    Aging Population and Increased Healthcare Expenditure

    The global demographic shift towards an aging population is a crucial factor influencing the Global Cardiac Implants Market Industry. Older adults are more susceptible to cardiovascular diseases, necessitating advanced medical interventions such as cardiac implants. Additionally, increased healthcare expenditure in many countries supports the adoption of these technologies. Governments and healthcare systems are investing in innovative treatments to address the growing burden of heart diseases. This trend is expected to contribute to the market's expansion, with projections indicating a growth trajectory that could see the market reach 125.7 USD Billion by 2035.

    Rising Awareness and Preventive Healthcare Initiatives

    Growing awareness regarding cardiovascular health and preventive healthcare initiatives are driving the Global Cardiac Implants Market Industry. Educational campaigns and community outreach programs are informing the public about the risks associated with heart diseases and the benefits of early intervention. This heightened awareness encourages individuals to seek medical advice and treatment, leading to increased demand for cardiac implants. Furthermore, healthcare providers are emphasizing preventive measures, which may result in earlier diagnoses and timely interventions. As a consequence, the market is likely to witness sustained growth as more patients opt for cardiac implants as a preventive measure.

    Market Segment Insights

    Cardiac Implants Indication Insights

    Based on Indication, the global market is segmented into Arrhythmias, myocardial ischemia, acute myocardial infarction, heart failure, and others.

    Cardiac Implants Device Insights

    The cardiac implant devices are segmented into implantable loop recorder, cardiac rhythm management devices, coronary stents, ventricular assist devices, and others.

    Cardiac Implants End-Users Insights

    On the basis of the end-users, market of cardiac implants is segmented into cardiac care centers, ambulatory centers, hospitals,  academic institutes, home care, and others.

    Get more detailed insights about Cardiac Implants Market

    Key Companies in the Cardiac Implants Market market include

    Industry Developments

    • Q2 2024: Medtronic receives FDA approval for next-generation Micra AV2 and Micra VR2 leadless pacemakers Medtronic announced that the U.S. FDA has approved its latest Micra AV2 and Micra VR2 leadless pacemakers, expanding options for patients needing cardiac rhythm management devices.
    • Q2 2024: Boston Scientific launches FARAPULSE Pulsed Field Ablation System in Europe Boston Scientific announced the commercial launch of its FARAPULSE Pulsed Field Ablation System for the treatment of atrial fibrillation in select European markets following CE Mark approval.
    • Q1 2024: Edwards Lifesciences receives FDA approval for SAPIEN 3 Ultra RESILIA heart valve Edwards Lifesciences announced U.S. FDA approval of its SAPIEN 3 Ultra RESILIA valve, a next-generation transcatheter heart valve designed to improve durability and patient outcomes.
    • Q2 2024: Abbott launches AVEIR DR dual chamber leadless pacemaker system in the U.S. Abbott announced the U.S. launch of its AVEIR DR dual chamber leadless pacemaker system, the first of its kind to receive FDA approval for treating patients with abnormal heart rhythms.
    • Q1 2024: Biotronik receives CE Mark for BIOMONITOR IV implantable cardiac monitor Biotronik announced it has received CE Mark approval for its BIOMONITOR IV, an implantable cardiac monitor designed for long-term heart rhythm monitoring.
    • Q2 2024: Boston Scientific completes $3.7 billion acquisition of Axonics Boston Scientific finalized its acquisition of Axonics, a company specializing in implantable sacral neuromodulation devices, expanding its portfolio in the cardiac and urology device markets.
    • Q1 2024: Medtronic launches Harmony Transcatheter Pulmonary Valve in Japan Medtronic announced the commercial launch of its Harmony Transcatheter Pulmonary Valve in Japan, following regulatory approval for use in patients with congenital heart disease.
    • Q2 2024: Abbott receives FDA approval for TriClip transcatheter tricuspid valve repair system Abbott announced that the U.S. FDA has approved its TriClip system, the first transcatheter device for repairing the tricuspid heart valve, offering a new treatment option for patients with tricuspid regurgitation.
    • Q1 2024: LivaNova appoints new CEO, Vladimir Makatsaria LivaNova, a global medical technology company specializing in cardiac surgery and neuromodulation, announced the appointment of Vladimir Makatsaria as its new Chief Executive Officer.
    • Q2 2024: Edwards Lifesciences opens new manufacturing facility in Ireland Edwards Lifesciences inaugurated a new manufacturing facility in Limerick, Ireland, to expand production capacity for its transcatheter heart valve technologies.
    • Q1 2024: CardioFocus receives FDA approval for HeartLight X3 Endoscopic Ablation System CardioFocus announced that the U.S. FDA has approved its HeartLight X3 Endoscopic Ablation System for the treatment of atrial fibrillation, enhancing options for minimally invasive cardiac procedures.
    • Q2 2024: Boston Scientific receives FDA approval for WATCHMAN FLX Pro Left Atrial Appendage Closure Device Boston Scientific announced U.S. FDA approval of its WATCHMAN FLX Pro device, designed to reduce stroke risk in patients with non-valvular atrial fibrillation.

    .

    Future Outlook

    Cardiac Implants Market Future Outlook

    The Global Cardiac Implants Market is projected to grow at a 9.82% CAGR from 2024 to 2035, driven by technological advancements, increasing prevalence of cardiovascular diseases, and rising healthcare expenditures.

    New opportunities lie in:

    • Develop innovative biocompatible materials for implantable devices.
    • Leverage telemedicine for remote monitoring of cardiac implant patients.
    • Expand into emerging markets with tailored cardiac solutions.

    By 2035, the market is expected to exhibit robust growth, positioning itself as a leader in cardiovascular health solutions.

    Market Segmentation

    Cardiac Implants End-User Outlook

    Cardiac Implants Regional Outlook

    Cardiac Implants Device Type Outlook

    Cardiac Implants Indication Type Outlook

    Report Scope

    Report Attribute/Metric Details
    Market Size 2032 USD 97.13 Billion
    Compound Annual Growth Rate (CAGR) 8.97% (2024-2032)
    Base Year 2023
    Forecast Period 2024-2032
    Historical Data 2019 & 2022
    Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Segments Covered Device, Indication, End User and Region
    Geographies Covered America, Europe, Asia-Pacific, and the Middle-East & Africa
    Countries Covered The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled Abbott (US), Amg International (Germany), Edwards Life Sciences Corporation (US), Braun Melsungen AG (Germany), Biotronik (US), Boston Scientific Corporation (US), LivaNova PLC (UK), Medtronic PLC (US), Syncardia Systems, Inc (Arizona), Terumo Corporation (Japan)
    Key Market Opportunities Increasing awareness and introducing the new advanced technologies
    Key Market Dynamics Rise in older adults and rising prevalence of chronic diseases

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the valuation of the Cardiac Implants Market?

    Cardiac implants market is expected to rise to a valuation of more than USD 97.13 Billion by 2032.

    What is the CAGR of the Cardiac Implants Market?

    The global market is expected to exhibit a strong 8.97% CAGR over the forecast period.

    What is the prime driver for the market?

    The increasing geriatric population and the increasing prevalence of chronic heart conditions are the major drivers for the global cardiac implants market.

    What is the key restraint on the Cardiac Implants Market?

    The high costs of cardiac implants are the key restraint against the global cardiac implants market.

    What is the leading regional segment of the Cardiac Implants Market?

    North America is likely to hold the largest share in the global cardiac implants market.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials